The prominent role of p38 mitogen-activated protein kinase in insulin-mediated enhancement of VCAM-1 expression in endothelial cells

International Journal of Immunopathology and Pharmacology

Volumn 20, Issue 3, 2007, Pages 539-555

  Madonna, R ^a   Massaro, M ^b   Pandolfi, A ^a   Consoli, A ^a   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

Atherosclerosis; Diabetes; Insulin; Insulin resistance; MAP kinases

Indexed keywords

1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; LY 379196; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; SMALL INTERFERING RNA; SP 600127; STRESS ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; WORTMANNIN;

ARTICLE; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; UMBILICAL VEIN;

EID: 34948861614     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463200702000312     Document Type: Article

References (60)

1. Beckman J.A., M.A. Creager and P. Libby. 2002. Diabetes and atherosclerosis: epidemiology, pathophysiology, and management. JAMA 287: 2570.
2. Turner R.C. and R.R. Holman. 1996. The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group. Ann. Med. 28:439.
3. Stout R.W. 1996. Hyperinsulinemia and atherosclerosis. Diabetes 45(S):45.
4. Cosentino F., M. Eto, P. De Paolis, B. van der Loo, M. Bachschmid, V. Ullrich, A. Kouroedov, C. Delli Gatti, H. Joch, M. Volpe and T.F. Luscher. 2003. High glucose causes upregulation of cyclooxygenase-2 and alters prostanoid profile in human endothelial cells: role of protein kinase C and reactive oxygen species. Circulation 107:1017.
5. Basta G., A.M. Schmidt and R. De Caterina. 2004. Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes. Cardiovasc. Res. 63:582.
6. Laakso M. 1996. Insulin resistance and coronary heart disease. Curr. Opin. Lipidol. 7:217.
7. Despres J.P., B. Lamarche, P. Mauriege, B. Cantin, G.R. Dagenais, S. Moorjani and P.J. Lupien. 1996. Hyperinsulinemia as an independent risk factor for ischemic heart disease. N. Engl. J. Med. 334:952.
8. Pyorala K. 1979. Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland. Diabetes Care 2:131.
9. Stout R.W. 1990. Insulin and atheroma. 20-yr perspective. Diabetes Care 13:631.
10. Cusi K., K. Maezono, A. Osman, M. Pendergrass, M.E. Patti, T. Pratipanawatr, R.A. DeFronzo, C.R. Kahn and L.J. Mandarino. 2000. Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. J. Clin. Invest. 105:311.
11. Soop M., H. Duxbury, A.O. Agwunobi, J.M. Gibson, S.J. Hopkins, C. Childs, R.G. Cooper, P. Maycock, R.A. Little and G.L. Carlson. 2002. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am. J. Physiol. Endocrinol. Metab. 282:E1276.
12. Sartipy P. and D.J. Loskutoff. 2003. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Scei. USA 100:7265.
13. Zeng G., F.H. Nystrom, L.V. Ravichandran, L.N. Cong, M. Kirby, H. Mostowski and M.J. Quon. 2000. Roles for insulin receptor, PI3-kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 101:1539.
14. Zeng G. and M.J. Quon. 1996. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells. J. Clin. Invest. 98:894.
15. De Caterina R., P. Libby, H.B. Peng, V.J. Thannickal, T.B. Rajavashisth, M.A. Gimbrone, Jr, W.S. Shin and J.K. Liao. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60.
16. Dandona P., A. Aljada and P. Mohanty. 2002. The anti-inflammatory and potential anti-atherogenic effect of insulin: a new paradigm. Diabetologia 45:924.
17. Madonna R., A. Pandolfi, M. Massaro, A. Consoli and R. De Caterina. 2004. Insulin enhances vascular cell adhesion molecule-1 expression in human cultured endothelial cells through a pro-atherogenic pathway mediated by p38 mitogen-activated protein-kinase. Diabetologia 47:532.
18. Cybulsky M.I., K. Iiyama, H. Li, S. Zhu, M. Chen, M. Iiyama, V. Davis, J.C. Gutierrez-Ramos, P.W. Connelly and D.S. Milstone. 2001. A major role for VCAM-1, but not ICAM-1, in early atherosclerosis. J. Clin. Invest. 107:1255.
19. Jiang Z.Y., Y.W. Lin, A. Clement, E.P. Feener, K.D. Hein, M. Igarashi, T. Yamauchi, M.F. White and G.L. King . 1999. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J. Clin. Invest. 104:447.
20. Han J., J.D. Lee, L. Bibbs and R.J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808.
21. Zhu W., J.S. Downey, J. Gu, F. Di Padova, H. Gram and J. Han. 2000. Regulation of TNF expression by multiple mitogen-activated protein kinase pathways. J. Immunol. 164:6349.
22. Viemann D., M. Goebeler, S. Schmid, K. Klimmek, C. Sorg, S. Ludwig and J. Roth. 2004. Transcriptional profiling of IKK2/NF-kappa B- and p38 MAP kinase-dependent gene expression in TNF-alpha-stimulated primary human endothelial cells. Blood 103:3365.
23. Kuldo J.M., J. Westra, S.A. Asgeirsdottir, R.J. Kok, K. Oosterhuis, M.G. Rots, J.P. Schouten, P.C. Limburg and G. Molema. 2005. Differential effects of NF-{kappa}B and p38 MAPK inhibitors and combinations thereof on TNF-{alpha}- and IL-1{beta}-induced proinflammatory status of endothelial cells in vitro. Am. J. Physiol. Cell Physiol. 289:C1229.
24. Orr A.W., J.M. Sanders, M. Bevard, E. Coleman, I.J. Sarembock and M.A. Schwartz. 2005. The subendothelial extracellular matrix modulates NF-kappaB activation by flow: a potential role in atherosclerosis. J. Cell Biol. 169:191.
25. Nadra I., J.C. Mason, P. Philippidis, O. Florey, C.D. Smythe, G.M. McCarthy, R.C. Landis and D.O. Haskard. 2005. Proinflammatory activation of macrophages by basic calcium phosphate crystals via protein kinase C and MAP kinase pathways: a vicious cycle of inflammation and arterial calcification? Circ. Res. 96:1248.
26. Amin M.A., C.S. Haas, K. Zhu, P.J. Mansfield, M.J. Kim, N.P. Lackowski and A.E. Koch. 2006. Migration inhibitory factor up-regulates vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 via Src, PI3 kinase, and NFkappaB. Blood 107:2252.
27. Lee J. and P.F. Pilch. 1994. The insulin receptor: structure, function, and signaling. Am. J. Physiol. 266:C319.
28. Badger A.M., J.N. Bradbeer, B. Votta, J.C. Lee, J.L. Adams and D.E. Griswold. 1996. Pharmacological profile of SB 203580, a selective inhibitor of cytokine suppressive binding protein/p38 kinase, in animal models of arthritis, bone resorption, endotoxin shock and immune function. J. Pharmacol. Exp. Then 279:1453.
29. Szlosarek P.W. and F.R. Balkwill. 2003. Tumour necrosis factor alpha: a potential target for the therapy of solid tumours. Lancet Oncol. 4:565.
30. Kacimi R., J.S. Karliner, F. Koudssi and C.S. Long. 1998. Expression and regulation of adhesion molecules in cardiac cells by cytokines: response to acute hypoxia. Circ. Res. 82:576.
31. Ju J.W., S.J. Kim, C.D. Jun and J.S. Chun. 2002. p38 kinase and c-Jun N-terminal kinase oppositely regulates tumor necrosis factor alpha-induced vascular cell adhesion molecule-1 expression and cell adhesion in chondrosarcoma cells. IUBMB Life 54:293.
32. Chen C.C., J.J. Chen and C.Y. Chou. 2000. Protein kinase calpha but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1beta: involvement of sequential activation of tyrosine kinase, nuclear factor-kappaB-inducing kinase, and IkappaB kinase 2. Mol. Pharmacol. 58:1479.
33. Chen C., C. Chou, Y. Sun and W. Huang. 2001. Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion. Involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs, pathway. Cell Signal. 13:543.
34. Bundy R.E., G.S. Hoare, A. Kite, J. Beach, M. Yacoub and N. Marczin. 2005. Redox regulation of p38 MAPK activation and expression of ICAM-1 and heme oxygenase-1 in human alveolar epithelial (A549) cells. Antioxid. Redox Signal. 7:14.
35. Rahman A., K.N. Anwar, S. Uddin, N. Xu, R.D. Ye, L.C. Platanias and A.B. Malik. 2001. Protein kinase C-delta regulates thrombin-induced ICAM-1 gene expression in endothelial cells via activation of p38 mitogen-activated protein kinase. Mol. Cell Biol. 21:5554.
36. Miho N., T. Ishida, N. Kuwaba, M. Ishida, K. Shimote-Abe, K. Tabuchi, T. Oshima, M. Yoshizumi and K. Chayama. 2005. Role of the JNK pathway in thrombin-induced ICAM-1 expression in endothelial cells. Cardiovasc. Res. 68:289.
37. Hyduk S.J., J.R. Chan, S.T. Duffy, M. Chen, M.D. Peterson, T.K. Waddell, G.C. Digby, K. Szaszi, A. Kapus and M.I. Cybulsky. 2007. Phospholipase C, calcium, and calmodulin are critical for alpha4beta1 integrin affinity up-regulation and monocyte arrest triggered by chemoattractants. Blood 109:176.
38. Johns D.G., Z. Ao, R.N. Willette, C.H. Macphee and S.A. Douglas. 2005. Role of p38 MAP kinase in postcapillary venule leukocyte adhesion induced by ischemia/reperfusion injury. Pharmacol. Res. 51:463.
39. Shibuya Y., N. Hirasawa, T. Sakai, Y. Togashi, R. Muramatsu, K. Ishii, M. Yamashita, M. Takayanagi and K. Ohuchi. 2004. Negative regulation of the protein kinase C activator-induced ICAM-1 expression in the human bronchial epithelial cell line NCI-H292 by p44/42 mitogen-activated protein kinase. Life Sci. 75:435.
40. Yamawaki H., S. Lehoux and B.C. Berk. 2003. Chronic physiological shear stress inhibits tumor necrosis factor-induced proinflammatory responses in rabbit aorta perfused ex vivo. Circulation 108:1619.
41. Aggarwal B.B. 2000. Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB. Ann. Rheum. Dis. 59(S):6.
42. Kyriakis J.M. and J. Avruch. 2001. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81:807.
43. Bian Z.M., S.G. Einer, A. Yoshida, S.L. Kunkel, J. Su and V.M. Einer. 2001. Activation of p38, ERK1/2 and NIK pathways is required for IL-1beta and TNF-alpha-induced chemokine expression in human retinal pigment epithelial cells. Exp. Eye Res. 73:111.
44. Wang C.C., W.N. Lin, C.W. Lee, C.C. Lin, S.F. Luo, J.S. Wang and C.M. Yang. 2005. Involvement of p42/p44 MAPK, p38 MAPK, JNK, and NF-kappaB in IL-1beta-induced VCAM-1 expression in human tracheal smooth muscle cells. Am. J. Physiol. Lung Cell Mol. Physiol. 288:227.
45. Saad M.F., W.C. Knowler, D.J. Pettitt, R.G. Nelson, D.M. Mott and P.H. Bennett. 1989. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes. Lancet 1:1356.
46. Golovchenko I., M.L. Goalstone, P. Watson, M. Brownlee and B. Draznin. 2000. Hyperinsulinemia enhances transcriptional activity of nuclear factor-kappaB induced by angiotensin II, hyperglycemia, and advanced glycosylation end products in vascular smooth muscle cells. Circ. Res. 87:746.
47. Wang C.C., I. Gurevich and B. Draznin. 2003. Insulin affects vascular smooth muscle cell phenotype and migration via distinct signaling pathways. Diabetes 52:2562.
48. Lee J.C. and P.R. Young. 1996. Role of CSB/p38/RK stress response kinase in LPS and cytokine signaling mechanisms. J. Leukoc. Biol. 59:152.
49. Davies S.P., H. Reddy, M. Caivano and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95.
50. Baldwin J.A.S. 1996. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol. 14:649.
51. Collins T., M.A. Read, A.S. Neish, M.Z. Whitley, D. Thanos and T. Maniatis. 1995. Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9:899.
52. Palombella V.J., O.J. Rando, A.L. Goldberg and T. Maniatis. 1994. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B. Cell 78:773.
53. Chen Z.J., L. Parent and T. Maniatis. 1996. Site-specific phosphorylation of IkappaBalpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853.
54. Dandona P., A. Aljada, P. Mohanty, H. Ghanim, W. Hamouda, E. Assian and S. Ahmad. 2001. Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: evidence for an anti-inflammatory effect? J. Clin. Endocrinol. Metab. 86:3257.
55. Bertrand F., C. Philippe, P.J. Antoine, L. Baud, A. Groyer, J. Capeau and G. Cherqui. 1995. Insulin activates nuclear factor kappa B in mammalian cells through a Raf-1-mediated pathway. J. Biol. Chem. 270:24435.
56. Schmidt A.M. and D.M. Stern. 2000. Hyperinsulinemia and vascular dysfunction: the role of nuclear factor-kappaB, yet again. Circ. Res. 87:722.
57. Foey A.D., S.L. Parry, L.M. Williams, M. Feldmann, B.M. Foxwell and F.M. Brennan. 1998. Regulation of monocyte IL-10 synthesis by endogenous IL-1 and TNF-alpha: role of the p38 and p42/44 mitogen-activated protein kinases. J. Immunol. 160:920.
58. Ridley S.H., S.J. Sarsfield, J.C. Lee, H.F. Bigg, T.E. Cawston, D.J. Taylor, D.L. DeWitt and J. Saklatvala. 1997. Actions of IL-1 are selectively controlled by p38 mitogen-activated protein kinase: regulation of prostaglandin H synthase-2, metalloproteinases, and IL-6 at different levels. J. Immunol. 158:3165.
59. Festa A., R. D'Agostino Jr, L. Mykkanen, R.P. Tracy, D.J. Zaccaro, C.N. Hales and S.M. Haffner. 1999. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS). Arterioscler. Thromb. Vasc. Biol. 19:562.
60. Baron A.D. 1996. Insulin and the vasculature - old actors, new roles. J. Investig. Med. 44:406.